A Systematic Review and Meta-Analysis of Efficacy and Safety of Liraglutide in Patients with Type 2 Diabetes Mellitus

20260 citationsJournal Articlegold Open Access

Authors

Shashank Joshi · Lilavati Hospital & Research Centre

Ashok Kumar Das · Sri Balaji Vidyapeeth University

Kamlesh Khunti · University of Leicester

Sachin Khunti · Leicester General Hospital

Sanjay Choudhari · Glenmark Pharmaceuticals (India)

Abstract

Liraglutide 1.2 mg and 1.8 mg doses improve weight and glycemic outcomes with a favourable safety profile, supporting its role as an effective therapeutic option for comprehensive management of T2DM with comorbid obesity.

Topics & Keywords

Diabetes Treatment and Management Bariatric Surgery and Outcomes Pharmacology and Obesity Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Metabolic Syndrome and Obesity

Volume Volume 19, pp. 1-24

DOI: 10.2147/dmso.s570273

Field-Weighted Citation Impact: 0.00